CA2594196A1 - Polymere inhibiteur de la protease - Google Patents

Polymere inhibiteur de la protease Download PDF

Info

Publication number
CA2594196A1
CA2594196A1 CA 2594196 CA2594196A CA2594196A1 CA 2594196 A1 CA2594196 A1 CA 2594196A1 CA 2594196 CA2594196 CA 2594196 CA 2594196 A CA2594196 A CA 2594196A CA 2594196 A1 CA2594196 A1 CA 2594196A1
Authority
CA
Canada
Prior art keywords
polymer
beads
hydroxamate
solution
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2594196
Other languages
English (en)
Inventor
Gary Alan Skarja
Michael H. May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rimon Therapeutics Ltd
Original Assignee
Rimon Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rimon Therapeutics Ltd filed Critical Rimon Therapeutics Ltd
Publication of CA2594196A1 publication Critical patent/CA2594196A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2594196 2006-07-21 2007-07-23 Polymere inhibiteur de la protease Abandoned CA2594196A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82001806P 2006-07-21 2006-07-21
US60/820,018 2006-07-21

Publications (1)

Publication Number Publication Date
CA2594196A1 true CA2594196A1 (fr) 2008-01-21

Family

ID=38973735

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2594196 Abandoned CA2594196A1 (fr) 2006-07-21 2007-07-23 Polymere inhibiteur de la protease

Country Status (1)

Country Link
CA (1) CA2594196A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010133906A2 (fr) * 2009-05-18 2010-11-25 Carlo Ghisalberti Utilisation de polymères chélatants spécifiques dans des médicaments pour le traitement de maladie intestinale inflammatoire

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010133906A2 (fr) * 2009-05-18 2010-11-25 Carlo Ghisalberti Utilisation de polymères chélatants spécifiques dans des médicaments pour le traitement de maladie intestinale inflammatoire
WO2010133906A3 (fr) * 2009-05-18 2011-01-13 Carlo Ghisalberti Utilisation de polymères chélatants spécifiques dans des médicaments pour le traitement de maladie intestinale inflammatoire

Similar Documents

Publication Publication Date Title
Nguyen et al. Roles of matrix metalloproteinases in cutaneous wound healing
Lalmanach et al. Kininogens: more than cysteine protease inhibitors and kinin precursors
Tarlton et al. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase‐9
Owen et al. The cell biology of leukocyte-mediated proteolysis
Van Lint et al. Matrix metalloproteinase-8: cleavage can be decisive
Itoh et al. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate
Tyagi et al. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity
Ray et al. Members of the cystatin superfamily interact with MMP-9 and protect it from autolytic degradation without affecting its gelatinolytic activities
Smeets et al. Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration
Tanriverdi‐Akhisaroglu et al. Matrix metalloproteinase‐2 and‐9 activities in human keloids, hypertrophic and atrophic scars: a pilot study
Skarja et al. The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases
Nagase Stromelysins 1 and 2
Rice et al. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix
Flight et al. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents
Prasa et al. Inhibition of thrombin generation in plasma by inhibitors of factor Xa
Terp et al. Structural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexes
Chang Matrix metalloproteinase profiling and their roles in disease
CA2594196A1 (fr) Polymere inhibiteur de la protease
US9694081B2 (en) Protease triggered release of molecules from hydrogels
Barrett et al. The unique nature of the interaction of α2-macroglobulin with proteinases
Hesek et al. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples
Kolkenbrock et al. Generation and activity of the ternary gelatinase b/timp-1/lmw-stromelysin-1 complex
Kluft The fibrinolytic system and thrombotic tendency
US20070160655A1 (en) Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases
Herouy et al. The role of matrix metalloproteinases (MMPs) and their inhibitors in venous leg ulcer healing

Legal Events

Date Code Title Description
FZDE Dead